Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenfluramine (ZX008) adjunctive therapy in Dravet syndrome – randomized placebo-controlled phase 3 trial in Japan
jRCT2080224792Phase 3Completed
- Sponsor
- Zogenix, Inc.
- Start
- Jul 2019
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of fenfluramine in Dravet syndrome (3 arms), sponsored by Zogenix, Inc. Started Jul 2019; status: completed.
02
Drugs
fenfluramine
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on jRCT2080224792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224792.